These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 31838587

  • 1. Matrix-assisted laser desorption/ionization mass spectrometry imaging to uncover protein alterations associated with the progression of IgA nephropathy.
    Ivanova M, Dyadyk O, Ivanov D, Clerici F, Smith A, Magni F.
    Virchows Arch; 2020 Jun; 476(6):903-914. PubMed ID: 31838587
    [Abstract] [Full Text] [Related]

  • 2. α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression.
    Smith A, L'Imperio V, De Sio G, Ferrario F, Scalia C, Dell'Antonio G, Pieruzzi F, Pontillo C, Filip S, Markoska K, Granata A, Spasovski G, Jankowski J, Capasso G, Pagni F, Magni F.
    Proteomics; 2016 Jun; 16(11-12):1759-66. PubMed ID: 26749278
    [Abstract] [Full Text] [Related]

  • 3. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry.
    Smith A, Iablokov V, Mazza M, Guarnerio S, Denti V, Ivanova M, Stella M, Piga I, Chinello C, Heijs B, van Veelen PA, Benediktsson H, Muruve DA, Magni F.
    Kidney Blood Press Res; 2020 Jun; 45(2):233-248. PubMed ID: 32062660
    [Abstract] [Full Text] [Related]

  • 4. Identification of mannose-binding lectin as a mechanism in progressive immunoglobulin A nephropathy.
    Shi B, Wang L, Mou S, Zhang M, Wang Q, Qi C, Cao L, Che X, Fang W, Gu L, Yan Y, Qian J, Ni Z.
    Int J Clin Exp Pathol; 2015 Jun; 8(2):1889-99. PubMed ID: 25973081
    [Abstract] [Full Text] [Related]

  • 5. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
    Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ.
    Proteomics; 2006 Feb; 6(3):1066-76. PubMed ID: 16372274
    [Abstract] [Full Text] [Related]

  • 6. [Feasibility of peptide mass fingerprinting for differential diagnosis of IgA and non-IgA nephropathy].
    Gao J, Wang Y, Wen XY, Lu HH, Dong ZN, Tian YP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1309-13. PubMed ID: 21868311
    [Abstract] [Full Text] [Related]

  • 7. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.
    Graterol F, Navarro-Muñoz M, Ibernon M, López D, Troya MI, Pérez V, Bonet J, Romero R.
    BMC Nephrol; 2013 Apr 11; 14():82. PubMed ID: 23577616
    [Abstract] [Full Text] [Related]

  • 8. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan 11; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 9. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 10. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J.
    J Biomed Nanotechnol; 2012 Feb 20; 8(1):133-9. PubMed ID: 22515101
    [Abstract] [Full Text] [Related]

  • 11. Application of Sparse Linear Discriminant Analysis and Elastic Net for Diagnosis of IgA Nephropathy: Statistical and Biological Viewpoints.
    Mohammadi Majd T, Kalantari S, Raeisi Shahraki H, Nafar M, Almasi A, Samavat S, Parvin M, Hashemian A.
    Iran Biomed J; 2018 Nov 20; 22(6):374-84. PubMed ID: 29523019
    [Abstract] [Full Text] [Related]

  • 12. NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis.
    Chen Y, Li H, Xiao C, Zeng X, Xiao X, Zhou Q, Xiao P.
    J Transl Med; 2018 Nov 19; 16(1):317. PubMed ID: 30453994
    [Abstract] [Full Text] [Related]

  • 13. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 14. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
    Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, Zheng K, Ye W, Cai G, Sun W, Li M.
    PeerJ; 2023 Jul 30; 11():e15125. PubMed ID: 37065697
    [Abstract] [Full Text] [Related]

  • 15. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
    Cichoń-Kawa K, Mizerska-Wasiak M, Małdyk J, Turczyn A, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Sikora P, Gadomska-Prokop K, Grenda R, Pańczyk-Tomaszewska M.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):177-182. PubMed ID: 29775444
    [Abstract] [Full Text] [Related]

  • 16. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine.
    Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V.
    Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696
    [Abstract] [Full Text] [Related]

  • 17. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 18. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
    Sakagami Y, Nakajima M, Takagawa K, Ueda T, Akazawa H, Maruhashi Y, Shimoyama H, Kamitsuji H, Yoshioka A.
    Nephron Clin Pract; 2004 Jan 22; 96(3):c96-104. PubMed ID: 15056992
    [Abstract] [Full Text] [Related]

  • 19. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 20. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C, Wang AY, Li G, Wang L.
    BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.